A highly active Angiopoietin 1 mimetic enhances angiogenesis in mouse models of choroidal neovascularization, suggesting potential for nvAMD treatment.
Does a highly active Angiopoietin 1 mimetic potentiate angiogenesis in mouse models of choroidal neovascularization?
Understanding the contexts of Tie2 activation is critical for developing new drugs for neovascular age-related macular degeneration.
Tasa de eventos absoluta: 0% vs 0%
Understanding the contexts under which Tie2 activation is beneficial and where it is harmful will be critical to successful development of new Tie2-activating drugs for nvAMD.
Youssif et al. (Thu,) reported a other. A highly active Angiopoietin 1 mimetic enhances angiogenesis in mouse models of choroidal neovascularization, suggesting potential for nvAMD treatment.